KALV R&D Expenses
Kalvista Pharmaceuticals Inc · R&D Expenses
KALV R&D Expenses
Latest reported$48.42Mperiod ending
KALV R&D Expenses ($1.96M → $48.42M)
Annual R&D Expenses
High-resolution chart · PNG
KALV r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 55,639,500 | |
| 71,709,000 | |
| 86,167,000 | |
| 80,276,000 | |
| 70,167,000 | |
| 41,286,000 | |
| 40,194,000 | |
| 35,021,000 | |
| 18,237,000 | |
| 12,666,000 | |
| 14,661,000 | |
| 8,285,000 | |
| 4,229,000 | |
| 1,959,000 |